Cubist Systematic Strategies, LLC Myriad Genetics Inc Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 265,987 shares of MYGN stock, worth $2.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
265,987
Previous 117,338
126.68%
Holding current value
$2.1 Million
Previous $1.04 Million
35.77%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding MYGN
# of Institutions
237Shares Held
95.4MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$73.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$38.9 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.2 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $637M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...